Pursuant to Regulations 30 and 47 of SEBI(LODR) Regulations, 2015, we are forwarding herewith copies of Newspaper clippings regarding Unaudited Consolidated & Standalone Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
TCM Limited has published its unaudited financial results for the quarter and nine months ended 31 December 2025 in Financial Express and Deepika newspapers on 14 February 2026, as required under SEBI (LODR) Regulations. On a standalone basis, total income from operations stood at Rs. 537.79 lakhs for Q3 FY26, down from Rs. 600.95 lakhs in Q3 FY25, and the company reported a net loss of Rs. 96.21 lakhs for the quarter versus a loss of Rs. 62.74 lakhs a year ago. For the nine-month period, standalone net loss widened to Rs. 285.39 lakhs from Rs. 115.67 lakhs, with EPS of (Rs. 3.15). On a consolidated basis, Q3 FY26 revenue was Rs. 577.41 lakhs with a net loss of Rs. 117.64 lakhs, and the nine-month consolidated net loss deepened sharply to Rs. 436.06 lakhs (EPS of Rs. (6.57)), compared to a loss of Rs. 262.66 lakhs in the same period last year. The full-year FY25 standalone result had been a profit of Rs. 314.92 lakhs, highlighting a significant turnaround into losses this fiscal year.
Shareholders should note a clear deterioration in performance: revenues are shrinking year-on-year and both standalone and consolidated losses have widened materially in 9M FY26, which is likely to weigh negatively on the stock. The earlier FY25 profit of Rs. 314.92 lakhs (standalone) has now flipped to a Rs. 285.39 lakhs loss year-to-date, signalling stress in core operations.